Related Experiment Video

Updated: Jul 9, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Analysis of ambulatory heart failure management and its incidence on one-year survival

F-A Allaert1, M Mosnier

  • 1Epidemiology and Biostatistics Department, McGill University, 845, rue Sherbrooke Ouest, Montreal, Québec, Canada, H3A 2T5. projet@cenbiotech.com <projet@cenbiotech.com>

Annales De Cardiologie Et D'Angeiologie
|December 7, 2007
PubMed

Insights

This study on heart failure (HF) patients found that combining ACE inhibitors and beta-blockers improved survival. While ACE inhibitor use is high, beta-blocker use and dosage need improvement for better patient outcomes.

Area of Science:

  • Cardiology
  • Clinical Practice
  • Pharmacotherapy

Background:

  • Heart failure (HF) management is complex, requiring adherence to international guidelines.
  • Optimizing pharmacotherapy is crucial for improving survival rates in HF patients.
  • Assessing real-world prescription patterns and their impact on outcomes is essential.

Purpose of the Study:

  • To evaluate one-year survival in a large cohort of heart failure patients.
  • To analyze survival rates based on clinical profiles and cardiologist management.
  • To assess the impact of specific drug classes, ACE inhibitors and beta-blockers, on HF patient outcomes.

Main Methods:

  • Prospective observational survey of 1941 heart failure patients.
  • One-year follow-up to assess patient survival.
  • Multifactorial modeling to identify predictors of outcome and treatment effects.

Main Results:

  • High prescription rates for ACE inhibitors, with dosages approaching guideline recommendations.
  • Significant deficit in beta-blocker prescription and suboptimal dosages observed.
  • Multifactorial analysis identified global heart failure, advanced NYHA class, and renal failure as predictors of poor outcome.
  • Combination therapy of ACE inhibitors and beta-blockers showed increased survival likelihood compared to monotherapy.

Conclusions:

  • The study highlights the need to enhance the prescription of ACE inhibitors and beta-blockers at effective doses, aligning with clinical guidelines.
  • A synergistic positive effect of combining ACE inhibitors and beta-blockers was observed in real-world heart failure management.
  • Findings aim to improve clinical practice and patient outcomes in heart failure care.
Abstract

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...